LiuYZhangCJiangL, et al.Relationship between high-sensitivity C-reactive protein and long-term outcomes in elderly patients with 3-vessel disease. Angiology. 2021:33197211021195.
2.
RidkerPM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
3.
RidkerPMStampferMJRifaiN. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. J Am Med Assoc. 2001;285:2481-2485.
4.
OzbayYAkbulutMBalinMKayancicekHBaydasAKorkmazH. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment. Mediators Inflamm. 2007;2007:89649.
5.
RencuzogullariIKarabagYCagdasM, et al.Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction. Rev Port Cardiol. 2019;38:269-277.
6.
CagdasMRencuzogullariIKarakoyunS, et al.Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2019;70:361-368.
7.
YaylaCGayretli YaylaK. C-Reactive protein to albumin ratio in patients with saphenous vein graft disease. Angiology. 2021;72:770-775.
8.
Gayretli YaylaKYaylaCErdolMAKaranfilMErtemAGAkcayAB. Relationship between C-Reactive protein to albumin ratio and infarct-related artery patency in patients with ST-segment elevation myocardial infarction. Angiology. 2021:33197211024047.
9.
ZhangNLiuWKangY. [Predictive value of plasma high-sensitivity C-reactive protein/albumin ratio for the death in patients with acute coronary syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33:573-577.
